Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Some common medications can lower PSA levels in 45-year-old German men.

Computational methods help design drugs targeting prostate cancer proteins.

Finasteride may reduce prostate tumor cell invasion and spread.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

Men with better urinary symptoms have a lower risk of death.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Endurance exercise may help BPH by lowering hormones and inflammation.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

A rare benign tumor was found in a man's scrotum, highlighting the need for accurate diagnosis.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Using finasteride with TIP extends time off period for prostate cancer patients.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Method accurately measures finasteride and tamsulosin in combined drug form.